Article info

Original research
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK

Authors

  1. Correspondence to Dr Hilary Glen; hilary.glen{at}ggc.scot.nhs.uk
View Full Text

Citation

Glen H, Bahl A, Fleure L, et al
A modified Delphi consensus regarding the clinical utility of triplet therapy in patients with metastatic hormone-sensitive prostate cancer patients in the UK

Publication history

  • Received June 14, 2024
  • Accepted October 22, 2024
  • First published November 27, 2024.
Online issue publication 
November 27, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.